Basic Information

Terpenoid ID TKC152829
Cell line 0
Protein target 1
DiseaseNCIT 0
ORDO 0
ICD 11

Active subnetwork


Terpenoid-cell-disease Activity Association

ID Cell Line Synonyms Value Unit Type NCIt ORDO
TKC152829 B16 B-16; B16 melanoma; B16 subline B78; B78 25400.0 nM IC50 C21790

Terpenoid-protein target Activity Association

ID Uniport Pref_name Gene name value unit type
TKC152829 Q9WKE8 Reverse transcriptase reverse transcriptase 2 ug.mL-1 IC50
TKC152829 P47199 Quinone oxidoreductase Cryz >10 ug ml-1 CD
TKC152829 Q96RI1 Bile acid receptor NR1H4 0 nM EC50
TKC152829 P14679 Tyrosinase TYR -2 % Inhibition
TKC152829 Q8TDU6 G-protein coupled bile acid receptor 1 GPBAR1 >0 % Efficacy

Protein target-disease Activity Association

Uniport ID Uniport Name ICD-11
Q96RI1 NR1H4_HUMAN Autoimmune liver disease [ICD-11: DB96]
Q96RI1 NR1H4_HUMAN Cholelithiasis [ICD-11: DC11]
Q96RI1 NR1H4_HUMAN Insomnia [ICD-11: 7A00-7A0Z]
Q96RI1 NR1H4_HUMAN Osteoarthritis [ICD-11: FA00-FA05]
Q96RI1 NR1H4_HUMAN Breast cancer [ICD-11: 2C60-2C6Y]
Q96RI1 NR1H4_HUMAN Non-alcoholic fatty liver disease [ICD-11: DB92]
Q96RI1 NR1H4_HUMAN Chronic kidney disease [ICD-11: GB61]
Q96RI1 NR1H4_HUMAN Skeletal anomaly [ICD-11: LD24]
Q96RI1 NR1H4_HUMAN Hepatic fibrosis/cirrhosis [ICD-11: DB93]
Q96RI1 NR1H4_HUMAN Hyper-lipoproteinaemia [ICD-11: 5C80]
Q96RI1 NR1H4_HUMAN Type 2 diabetes mellitus [ICD-11: 5A11]
P14679 TYRO_HUMAN Acquired hypermelanosis [ICD-11: ED60]
P14679 TYRO_HUMAN Acquired hypomelanotic disorder [ICD-11: ED63]
P14679 TYRO_HUMAN Melanoma [ICD-11: 2C30]
P14679 TYRO_HUMAN Acquired melanotic macule/lentigine [ICD-11: ED61]
P14679 TYRO_HUMAN Mineral absorption/transport disorder [ICD-11: 5C64]
P14679 TYRO_HUMAN Skin pigmentation genetic disorder [ICD-11: EC23]
P14679 TYRO_HUMAN Rheumatoid arthritis [ICD-11: FA20]
Q8TDU6 GPBAR_HUMAN Type 2 diabetes mellitus [ICD-11: 5A11]
Q8TDU6 GPBAR_HUMAN Hepatic fibrosis/cirrhosis [ICD-11: DB93]
Q8TDU6 GPBAR_HUMAN Metabolic disorder [ICD-11: 5C50-5D2Z]